{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:40:12Z","timestamp":1793144412630,"version":"4.5.0"},"reference-count":109,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:00:00Z","timestamp":1600300800000},"content-version":"vor","delay-in-days":2543,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1194\/jlr.r035725","type":"journal-article","created":{"date-parts":[[2013,2,25]],"date-time":"2013-02-25T01:07:56Z","timestamp":1361754476000},"page":"2575-2585","source":"Crossref","is-referenced-by-count":318,"title":["Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond"],"prefix":"10.1016","volume":"54","author":[{"given":"Amy S.","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lirong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason Lu","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Sean","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1194\/jlr.R035725_bib1","first-page":"485","article-title":"Recherches sur les phosphoaminolipides du s\u00e9rum sanguin. Nature des phospholipides li\u00e9s aux albumines du s\u00e9rum de Cheval \u00e0 l\u2019\u00e9tat de cenapses acido-pr\u00e9cipitables","volume":"11","author":"Macheboeuf","year":"1929","journal-title":"Bull. Soc. Chim. Biol. (Paris)."},{"key":"10.1194\/jlr.R035725_bib2","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1021\/bi00848a011","article-title":"Heterogeneity in protein subunits of human serum high-density lipoproteins","volume":"7","author":"Shore","year":"1968","journal-title":"Biochemistry."},{"key":"10.1194\/jlr.R035725_bib3","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1021\/bi00836a027","article-title":"Fractionation of human serum high density lipoprotein in urea solutions. Evidence for polypeptide heterogeneity","volume":"8","author":"Scanu","year":"1969","journal-title":"Biochemistry."},{"key":"10.1194\/jlr.R035725_bib4","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1172\/JCI106245","article-title":"A new method for isolating the nonidentical protein subunits of human plasma alpha-lipoprotein","volume":"49","author":"Rudman","year":"1970","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.R035725_bib5","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/0014-5793(71)80648-8","article-title":"Studies of the composition and structure of plasma lipoproteins. C- and N-terminal amino acids of the two nonidentical polypeptides of human plasma apolipoprotein A","volume":"15","author":"Kostner","year":"1971","journal-title":"FEBS Lett."},{"key":"10.1194\/jlr.R035725_bib6","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1021\/bi00839a043","article-title":"Isolation and characterization of polypeptides of human serum lipoproteins","volume":"8","author":"Shore","year":"1969","journal-title":"Biochemistry."},{"key":"10.1194\/jlr.R035725_bib7","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1016\/S0021-9258(17)40346-2","article-title":"Interaction of canine and swine lipoproteins with the low density lipoprotein receptor of fibroblasts as correlated with heparin\/manganese precipitability","volume":"252","author":"Mahley","year":"1977","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R035725_bib8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0300-9084(80)80370-1","article-title":"Presence and isolation of 2 lipoproteins immunologically related to apolipoprotein A I in human serum [article in French]","volume":"62","author":"Ayrault-Jarrier","year":"1980","journal-title":"Biochimie."},{"key":"10.1194\/jlr.R035725_bib9","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1021\/bi00599a014","article-title":"Isolation and partial characterization of a new acidic apolipoprotein (apolipoprotein F) from high density lipoproteins of human plasma","volume":"17","author":"Olofsson","year":"1978","journal-title":"Biochemistry."},{"key":"10.1194\/jlr.R035725_bib10","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1084\/jem.152.3.641","article-title":"Heterogeneity of human serum amyloid A proteins","volume":"152","author":"Bausserman","year":"1980","journal-title":"J. Exp. Med."},{"key":"10.1194\/jlr.R035725_bib11","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0022-2275(20)38507-2","article-title":"Apolipoprotein distribution in human lipoproteins separated by polyacrylamide gradient gel electrophoresis","volume":"29","author":"V\u00e9zina","year":"1988","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.R035725_bib12","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/j.1432-1033.1993.tb17620.x","article-title":"Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45. Identity of K-45 with paraoxonase","volume":"211","author":"Blatter","year":"1993","journal-title":"Eur. J. Biochem."},{"key":"10.1194\/jlr.R035725_bib13","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0003-9861(86)90022-6","article-title":"Distribution of lipids and apolipoproteins in human plasma by vertical spin ultracentrifugation","volume":"249","author":"Campos","year":"1986","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1194\/jlr.R035725_bib14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0021-9150(80)90078-7","article-title":"Transfer of cholesterol esters between human high density lipoproteins and triglyceride-rich lipoproteins controlled by a plasma protein factor","volume":"35","author":"Marcel","year":"1980","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.R035725_bib15","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0022-2275(20)34314-5","article-title":"Plasma phospholipid transfer protein enhances transfer and exchange of phospholipids between very low density lipoproteins and high density lipoproteins during lipolysis","volume":"26","author":"Tall","year":"1985","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.R035725_bib16","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1016\/S0021-9258(18)61335-3","article-title":"Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor","volume":"262","author":"Stafforini","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R035725_bib17","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/S0022-2275(20)38408-X","article-title":"Protein heterogeneity of lipoprotein particles containing apolipoprotein A-I without apolipoprotein A-II and apolipoprotein A-I with apolipoprotein A-II isolated from human plasma","volume":"29","author":"James","year":"1988","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.R035725_bib18","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1126\/science.2675315","article-title":"Electrospray ionization for mass spectrometry of large biomolecules","volume":"246","author":"Fenn","year":"1989","journal-title":"Science."},{"key":"10.1194\/jlr.R035725_bib19","doi-asserted-by":"crossref","first-page":"1193A","DOI":"10.1021\/ac00024a716","article-title":"Matrix-assisted laser desorption\/ionization mass spectrometry of biopolymers","volume":"63","author":"Hillenkamp","year":"1991","journal-title":"Anal. Chem."},{"key":"10.1194\/jlr.R035725_bib20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/bfgp\/eli002","article-title":"Mass spectrometry technologies for proteomics","volume":"4","author":"Ca\u00f1as","year":"2006","journal-title":"Brief Funct. Genomic Proteomic."},{"key":"10.1194\/jlr.R035725_bib21","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/pmic.200401010","article-title":"Lipoproteomics II: mapping of proteins in high-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry","volume":"5","author":"Karlsson","year":"2005","journal-title":"Proteomics."},{"key":"10.1194\/jlr.R035725_bib22","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/pmic.200500191","article-title":"Proteomic analysis of high-density lipoprotein","volume":"6","author":"Rezaee","year":"2006","journal-title":"Proteomics."},{"key":"10.1194\/jlr.R035725_bib23","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1172\/JCI26206","article-title":"Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL","volume":"117","author":"Vaisar","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.R035725_bib24","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1002\/pmic.200401233","article-title":"Mass spectrometry-based analytical tools for the molecular protein characterization of human plasma lipoproteins","volume":"5","author":"Heller","year":"2005","journal-title":"Proteomics."},{"key":"10.1194\/jlr.R035725_bib25","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.bbrc.2005.12.098","article-title":"Diverse range of small peptides associated with high-density lipoprotein","volume":"340","author":"Hortin","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1194\/jlr.R035725_bib26","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1161\/ATVBAHA.109.186031","article-title":"Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function","volume":"29","author":"Davidson","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.R035725_bib27","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.bbalip.2011.07.013","article-title":"The HDL proteome in acute coronary syndromes shifts to an inflammatory profile","volume":"1821","author":"Alwaili","year":"2012","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1194\/jlr.R035725_bib28","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1194\/jlr.M027367","article-title":"Psoriasis alters HDL composition and cholesterol efflux capacity","volume":"53","author":"Holzer","year":"2012","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.R035725_bib29","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.2010111144","article-title":"Uremia alters HDL composition and function","volume":"22","author":"Holzer","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1194\/jlr.R035725_bib30","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1681\/ASN.2011070668","article-title":"Serum amyloid A in uremic HDL promotes inflammation","volume":"23","author":"Weichhart","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1194\/jlr.R035725_bib31","doi-asserted-by":"crossref","first-page":"e34107","DOI":"10.1371\/journal.pone.0034107","article-title":"HDL proteome in hemodialysis patients: a quantitative nanoflow liquid chromatography-tandem mass spectrometry approach","volume":"7","author":"Mang\u00e9","year":"2012","journal-title":"PLoS ONE."},{"key":"10.1194\/jlr.R035725_bib32","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1002\/art.34363","article-title":"Proteomic profiling following immunoaffinity capture of high-density lipoprotein: association of acute-phase proteins and complement factors with proinflammatory high-density lipoprotein in rheumatoid arthritis","volume":"64","author":"Watanabe","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1194\/jlr.R035725_bib33","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.1021\/pr100520x","article-title":"Proteomic characterization of human plasma high density lipoprotein fractionated by gel filtration chromatography","volume":"9","author":"Gordon","year":"2010","journal-title":"J. Proteome Res."},{"key":"10.1194\/jlr.R035725_bib34","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1194\/jlr.M700274-JLR200","article-title":"The roles of different pathways in the release of cholesterol from macrophages","volume":"48","author":"Adorni","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.R035725_bib35","doi-asserted-by":"crossref","first-page":"26338","DOI":"10.1074\/jbc.273.41.26338","article-title":"The efficient cellular uptake of high density lipoprotein lipids via scavenger receptor class B type I requires not only receptor-mediated surface binding but also receptor-specific lipid transfer mediated by its extracellular domain","volume":"273","author":"Gu","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R035725_bib36","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1161\/01.RES.0000185320.82962.F7","article-title":"Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased inflammation","volume":"97","author":"Moore","year":"2005","journal-title":"Circ. Res."},{"key":"10.1194\/jlr.R035725_bib37","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0022-2275(20)33462-3","article-title":"Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein. Steps 2 and 3","volume":"41","author":"Navab","year":"2000","journal-title":"J. Lipid Res."},{"issue":"Suppl","key":"10.1194\/jlr.R035725_bib38","doi-asserted-by":"crossref","first-page":"S195","DOI":"10.1194\/jlr.R800034-JLR200","article-title":"The metabolism and anti-atherogenic properties of HDL","volume":"50","author":"Rye","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.R035725_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0021-9150(95)05675-0","article-title":"High density lipoproteins and coronary heart disease","volume":"121","author":"Barter","year":"1996","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.R035725_bib40","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1172\/JCI115532","article-title":"Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein","volume":"88","author":"Navab","year":"1991","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.R035725_bib41","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.atherosclerosis.2007.05.008","article-title":"Low dose apolipoprotein A-I rescues carotid arteries from inflammation in vivo","volume":"196","author":"Puranik","year":"2008","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.R035725_bib42","series-title":"Function and Therapeutics.","article-title":"High-Density Lipoproteins: Structure, Metabolism,","author":"Kontush","year":"2012"},{"key":"10.1194\/jlr.R035725_bib43","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1146\/annurev.nu.14.070194.002431","article-title":"Transthyretin (prealbumin) in health and disease: nutritional implications","volume":"14","author":"Ingenbleek","year":"1994","journal-title":"Annu. Rev. Nutr."},{"key":"10.1194\/jlr.R035725_bib44","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1084\/jem.144.4.1121","article-title":"Murine model for human secondary amyloidosis: genetic variability of the acute-phase serum protein SAA response to endotoxins and casein","volume":"144","author":"McAdam","year":"1976","journal-title":"J. Exp. Med."},{"key":"10.1194\/jlr.R035725_bib45","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1161\/01.ATV.20.3.763","article-title":"Role of serum amyloid A during metabolism of acute-phase HDL by macrophages","volume":"20","author":"Artl","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.R035725_bib46","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1194\/jlr.M000323","article-title":"Myeloperoxidase and serum amyloid A contribute to impaired in vivo reverse cholesterol transport during the acute phase response but not group IIA secretory phospholipase A(2)","volume":"51","author":"Annema","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.R035725_bib47","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1172\/JCI31539","article-title":"SR-BI protects against endotoxemia in mice through its roles in glucocorticoid production and hepatic clearance","volume":"118","author":"Cai","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.R035725_bib48","doi-asserted-by":"crossref","first-page":"7172","DOI":"10.1074\/jbc.274.11.7172","article-title":"The heparin\/heparan sulfate-binding site on apo-serum amyloid A. Implications for the therapeutic intervention of amyloidosis","volume":"274","author":"Ancsin","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R035725_bib49","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1194\/jlr.R400017-JLR200","article-title":"Thematic review series: The immune system and atherogenesis. Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease?","volume":"46","author":"Chait","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.R035725_bib50","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1172\/JCI110833","article-title":"Inhibition of the lytic action of cell-bound terminal complement components by human high density lipoproteins and apoproteins","volume":"71","author":"Rosenfeld","year":"1983","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.R035725_bib51","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1084\/jem.179.1.269","article-title":"Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14","volume":"179","author":"Hailman","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1194\/jlr.R035725_bib52","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/MED.0b013e328337278b","article-title":"High-density lipoprotein and the acute phase response","volume":"17","author":"Jahangiri","year":"2010","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1194\/jlr.R035725_bib53","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1440-1681.2010.05377.x","article-title":"High-density lipoproteins, platelets and the pathogenesis of atherosclerosis","volume":"37","author":"Nofer","year":"2010","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1194\/jlr.R035725_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MCA.0b013e32835aab80","article-title":"High-density lipoprotein cholesterol and intracoronary thrombosis burden","volume":"24","author":"Wang","year":"2013","journal-title":"Coron. Artery Dis."},{"key":"10.1194\/jlr.R035725_bib55","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/clc.20692","article-title":"Correlation study of pulmonary embolism and high-density lipoprotein cholesterol","volume":"33","author":"Wang","year":"2010","journal-title":"Clin. Cardiol."},{"key":"10.1194\/jlr.R035725_bib56","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0006-2944(85)90059-6","article-title":"Plasma lipoproteins affect platelet malondialdehyde and thromboxane B2 production","volume":"34","author":"Aviram","year":"1985","journal-title":"Biochem. Med."},{"key":"10.1194\/jlr.R035725_bib57","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0022-2143(96)90097-9","article-title":"Reversal by high-density lipoprotein of the effect of oxidized low-density lipoprotein on nitric oxide synthase protein expression in human platelets","volume":"127","author":"Mehta","year":"1996","journal-title":"J. Lab. Clin. Med."},{"key":"10.1194\/jlr.R035725_bib58","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1172\/JCI5006","article-title":"High-density lipoprotein enhancement of anticoagulant activities of plasma protein S and activated protein C","volume":"103","author":"Griffin","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.R035725_bib59","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1172\/JCI42260","article-title":"Reevaluation of the role of HDL in the anticoagulant activated protein C system in humans","volume":"120","author":"Oslakovic","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.R035725_bib60","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1161\/ATVBAHA.108.162347","article-title":"Thrombocytopenia and platelet abnormalities in high-density lipoprotein receptor-deficient mice","volume":"28","author":"Dole","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.R035725_bib61","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1161\/CIRCULATIONAHA.109.870709","article-title":"Reconstituted high-density lipoprotein attenuates platelet function in individuals with type 2 diabetes mellitus by promoting cholesterol efflux","volume":"120","author":"Calkin","year":"2009","journal-title":"Circulation."},{"key":"10.1194\/jlr.R035725_bib62","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1111\/j.1432-1033.2004.04228.x","article-title":"Apolipoproteins A-I and A-II are potentially important effectors of innate immunity in the teleost fish Cyprinus carpio","volume":"271","author":"Concha","year":"2004","journal-title":"Eur. J. Biochem."},{"key":"10.1194\/jlr.R035725_bib63","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.fsi.2006.10.008","article-title":"Apolipoprotein A-I, an antimicrobial protein in Oncorhynchus mykiss: evaluation of its expression in primary defence barriers and plasma levels in sick and healthy fish","volume":"23","author":"Villarroel","year":"2007","journal-title":"Fish Shellfish Immunol."},{"key":"10.1194\/jlr.R035725_bib64","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cbpb.2008.06.011","article-title":"Apolipoprotein A-I from striped bass (Morone saxatilis) demonstrates antibacterial activity in vitro","volume":"151","author":"Johnston","year":"2008","journal-title":"Comp. Biochem. Physiol. B Biochem. Mol. Biol."},{"key":"10.1194\/jlr.R035725_bib65","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1172\/JCI34189","article-title":"Host-derived oxidized phospholipids and HDL regulate innate immunity in human leprosy","volume":"118","author":"Cruz","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.R035725_bib66","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0928-8244(03)00125-1","article-title":"Serum high-density lipoprotein (HDL) inhibits in vitro enterohemolysin (EHly) activity produced by enteropathogenic Escherichia coli","volume":"38","author":"Figueir\u00eado","year":"2003","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1194\/jlr.R035725_bib67","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0022-2275(20)33363-0","article-title":"Lipoproteins inhibit macrophage activation by lipoteichoic acid","volume":"40","author":"Grunfeld","year":"1999","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.R035725_bib68","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/abbs\/36.6.419","article-title":"Role of apolipoprotein A-I in protecting against endotoxin toxicity","volume":"36","author":"Ma","year":"2004","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)."},{"key":"10.1194\/jlr.R035725_bib69","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1128\/iai.63.1.253-258.1995","article-title":"Reconstituted high-density lipoprotein neutralizes gram-negative bacterial lipopolysaccharides in human whole blood","volume":"63","author":"Parker","year":"1995","journal-title":"Infect. Immun."},{"key":"10.1194\/jlr.R035725_bib70","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cyto.2008.04.002","article-title":"Apolipoprotein A-I diminishes acute lung injury and sepsis in mice induced by lipoteichoic acid","volume":"43","author":"Jiao","year":"2008","journal-title":"Cytokine."},{"key":"10.1194\/jlr.R035725_bib71","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ejphar.2008.06.047","article-title":"Human ApoA-I overexpression diminishes LPS-induced systemic inflammation and multiple organ damage in mice","volume":"590","author":"Li","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1194\/jlr.R035725_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1194\/jlr.E012138","article-title":"The role of HDL in innate immunity","volume":"52","author":"Feingold","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.R035725_bib73","doi-asserted-by":"crossref","first-page":"5515","DOI":"10.1074\/jbc.M512538200","article-title":"Serum opacity factor, a streptococcal virulence factor that binds to apolipoproteins A-I and A-II and disrupts high density lipoprotein structure","volume":"281","author":"Courtney","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R035725_bib74","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.cca.2010.03.023","article-title":"HDL in humans with cardiovascular disease exhibits a proteomic signature","volume":"411","author":"Vaisar","year":"2010","journal-title":"Clin. Chim. Acta."},{"key":"10.1194\/jlr.R035725_bib75","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1161\/CIRCULATIONAHA.108.770669","article-title":"Combined statin and niacin therapy remodels the high-density lipoprotein proteome","volume":"118","author":"Green","year":"2008","journal-title":"Circulation."},{"key":"10.1194\/jlr.R035725_bib76","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1194\/jlr.M018010","article-title":"Changes in lipoprotein subfraction concentration and composition in healthy individuals treated with the CETP inhibitor anacetrapib","volume":"53","author":"Krauss","year":"2012","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.R035725_bib77","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1161\/ATVBAHA.110.212894","article-title":"Low clusterin levels in high-density lipoprotein associate with insulin resistance, obesity, and dyslipoproteinemia","volume":"30","author":"Hoofnagle","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.R035725_bib78","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.steroids.2012.01.002","article-title":"Acute sex steroid withdrawal increases cholesterol efflux capacity and HDL-associated clusterin in men","volume":"77","author":"Rubinow","year":"2012","journal-title":"Steroids."},{"key":"10.1194\/jlr.R035725_bib79","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1194\/jlr.P026005","article-title":"Testosterone replacement in hypogonadal men alters the HDL proteome but not HDL cholesterol efflux capacity","volume":"53","author":"Rubinow","year":"2012","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.R035725_bib80","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0167-4838(99)00009-6","article-title":"Kinetics and mechanism of exchange of apolipoprotein C-III molecules from very low density lipoprotein particles","volume":"1430","author":"Boyle","year":"1999","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1194\/jlr.R035725_bib81","doi-asserted-by":"crossref","first-page":"12E","DOI":"10.1016\/S0002-9149(02)03383-0","article-title":"High-density lipoprotein subpopulations in pathologic conditions","volume":"91","author":"Asztalos","year":"2003","journal-title":"Am. J. Cardiol."},{"key":"10.1194\/jlr.R035725_bib82","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1194\/jlr.M700362-JLR200","article-title":"Characterization of high density lipoprotein particles in familial apolipoprotein A-I deficiency","volume":"49","author":"Santos","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.R035725_bib83","series-title":"Mol Cell Proteomics.","article-title":"Multi-dimensional co-separation analysis reveals protein:protein interactions defining plasma lipoprotein subspecies","author":"Gordon","year":"2013"},{"key":"10.1194\/jlr.R035725_bib84","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0005-2760(91)90062-M","article-title":"Lecithin-cholesterol acyltransferase in the metabolism of high-density lipoproteins","volume":"1084","author":"Jonas","year":"1991","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1194\/jlr.R035725_bib85","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1073\/pnas.74.11.4848","article-title":"Activation of lipoprotein lipase by native and synthetic fragments of human plasma apolipoprotein C-II","volume":"74","author":"Kinnunen","year":"1977","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1194\/jlr.R035725_bib86","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1194\/jlr.M400212-JLR200","article-title":"Evidence that endothelial lipase remodels high density lipoproteins without mediating the dissociation of apolipoprotein A-I","volume":"46","author":"Jahangiri","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.R035725_bib87","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1074\/jbc.274.3.1814","article-title":"Molecular cloning and expression of lipid transfer inhibitor protein reveals its identity with apolipoprotein F","volume":"274","author":"Wang","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R035725_bib88","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0014-5793(91)80962-3","article-title":"Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein","volume":"286","author":"Mackness","year":"1991","journal-title":"FEBS Lett."},{"key":"10.1194\/jlr.R035725_bib89","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1161\/01.ATV.18.10.1617","article-title":"Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase\/paraoxonase activities: selective action of human paraoxonase allozymes Q and R","volume":"18","author":"Aviram","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.R035725_bib90","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1172\/JCI118359","article-title":"Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein","volume":"96","author":"Watson","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.R035725_bib91","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0021-9150(94)05524-M","article-title":"HDL, its enzymes and its potential to influence lipid peroxidation","volume":"115","author":"Mackness","year":"1995","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.R035725_bib92","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.lfs.2011.10.018","article-title":"The anti-inflammatory effect of paraoxonase 1 against oxidized lipids depends on its association with high density lipoproteins","volume":"90","author":"Loued","year":"2012","journal-title":"Life Sci."},{"key":"10.1194\/jlr.R035725_bib93","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1172\/JCI1649","article-title":"Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase","volume":"101","author":"Aviram","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.R035725_bib94","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/iub.588","article-title":"Coincubation of PON1, APO A1, and LCAT increases the time HDL is able to prevent LDL oxidation","volume":"64","author":"Hine","year":"2012","journal-title":"IUBMB Life."},{"key":"10.1194\/jlr.R035725_bib95","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1073\/pnas.75.7.3450","article-title":"Identification of the trypanocidal factor in normal human serum: high density lipoprotein","volume":"75","author":"Rifkin","year":"1978","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1194\/jlr.R035725_bib96","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1016\/S0021-9258(18)83720-6","article-title":"Lysis of Trypanosoma brucei by a toxic subspecies of human high density lipoprotein","volume":"264","author":"Hajduk","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R035725_bib97","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nature01461","article-title":"Apolipoprotein L-I is the trypanosome lytic factor of human serum","volume":"422","author":"Vanhamme","year":"2003","journal-title":"Nature."},{"key":"10.1194\/jlr.R035725_bib98","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1073\/pnas.0609902104","article-title":"Distinct roles of haptoglobin-related protein and apolipoprotein L-I in trypanolysis by human serum","volume":"104","author":"Vanhollebeke","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1194\/jlr.R035725_bib99","doi-asserted-by":"crossref","first-page":"32578","DOI":"10.1074\/jbc.M503510200","article-title":"Human high density lipoproteins are platforms for the assembly of multi-component innate immune complexes","volume":"280","author":"Shiflett","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R035725_bib100","doi-asserted-by":"crossref","first-page":"7314","DOI":"10.1021\/bi100359f","article-title":"Phospholipid transfer protein in human plasma associates with proteins linked to immunity and inflammation","volume":"49","author":"Cheung","year":"2010","journal-title":"Biochemistry."},{"key":"10.1194\/jlr.R035725_bib101","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1373\/clinchem.2011.173856","article-title":"Multiple-reaction monitoring-mass spectrometric assays can accurately measure the relative protein abundance in complex mixtures","volume":"58","author":"Hoofnagle","year":"2012","journal-title":"Clin. Chem."},{"key":"10.1194\/jlr.R035725_bib102","doi-asserted-by":"crossref","first-page":"jah3","DOI":"10.1161\/JAHA.111.000232","article-title":"Apolipoprotein C-III as a potential modulator of the association between HDL-cholesterol and incident coronary heart disease","volume":"1","author":"Jensen","year":"2012","journal-title":"J. Am. Heart Assoc."},{"key":"10.1194\/jlr.R035725_bib103","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","article-title":"Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy","volume":"365","author":"Boden","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.R035725_bib104","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of torcetrapib in patients at high risk for coronary events","volume":"357","author":"Barter","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.R035725_bib105","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","article-title":"Effects of dalcetrapib in patients with a recent acute coronary syndrome","volume":"367","author":"Schwartz","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.R035725_bib106","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s11886-012-0317-3","article-title":"Targeting high density lipoproteins in the prevention of cardiovascular disease?","volume":"14","author":"Larach","year":"2012","journal-title":"Curr. Cardiol. Rep."},{"key":"10.1194\/jlr.R035725_bib107","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1001689","article-title":"Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis","volume":"364","author":"Khera","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.R035725_bib108","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1161\/01.CIR.0000103624.14436.4B","article-title":"Inflammatory\/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment","volume":"108","author":"Ansell","year":"2003","journal-title":"Circulation."},{"key":"10.1194\/jlr.R035725_bib109","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1161\/CIRCULATIONAHA.108.772665","article-title":"Cholesteryl ester transfer protein inhibitor torcetrapib and off-target toxicity: a pooled analysis of the rating atherosclerotic disease change by imaging with a new CETP inhibitor (RADIANCE) trials","volume":"118","author":"Vergeer","year":"2008","journal-title":"Circulation."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520352846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520352846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1194\/jlr.R035725","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T18:59:30Z","timestamp":1637434770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227520352846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":109,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0022227520352846"],"URL":"https:\/\/doi.org\/10.1194\/jlr.r035725","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}